CINVANTI (aprepitant)

**Product type:** Human Prescription Drug

**Active ingredient:** APREPITANT

**Strength:** 130 mg/18mL

**Dosage form:** Injection, Emulsion

**Route:** Intravenous

**Labeler:** Heron Therapeutics, Inc.

**Marketing category:** NDA (NDA209296)

**Pharmacologic class:** Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]